The PennZone

  • Home
  • Non-profit
  • Technology
  • Education
  • Business
  • Construction
  • Entertainment
  • Health
  • Software

Greenphire Enhances Patient Convenience Solutions, Supporting Clinical Trial Sites with Recruitment and Retention Worldwide
The PennZone/10123847

Trending...
  • Calvetta Phair, CEO America's Workforce Solution, LLC Assessed "Awardable" for Department of War work in the CDAO's Tradewinds Solutions Marketplace
  • Creative Investment Research Analysis Finds Slower GDP Growth, Rising Inflation
  • Tru by Hilton El Paso Airport Opens to Guests
KING OF PRUSSIA, Pa., May 4, 2021 /PRNewswire/ -- Greenphire, the global leader in financial lifecycle management for clinical trials, today announced sharp growth of its patient convenience solutions, ClinCard and ConneX, worldwide. The company, which now serves investigator sites in more than 70 countries, also made strategic enhancements to its solutions that support adoption, training, and usage of technologies.

ConneX®,  the trusted participant travel service designed to eliminate logistical barriers to participation in global clinical trials, has now facilitated travel in 34 countries, with the ability to arrange travel and accommodations worldwide. Notably, after going live with in-country support in China, Greenphire has already executed more than 200 patient itineraries. In addition, the number of studies using ConneX increased by 62% and the number of itineraries by 40% since the start of 2020, with notable increases in France and Russia.

Greenphire has also continued to evolve its ClinCard solution, the industry-leading method for automating participant payments and reimbursements, driving operational efficiency for sites and improved experience for participants around the world. The ClinCard portal is now translated into 17 different languages, including French, Polish, and Spanish. The company also initiated a dedicated site training team with EU and APAC time zones supported, demonstrating its commitment and motivation to provide a high quality and user-friendly experience for sites around the world.

More on The PennZone
  • 2026 Editorial Freelancers Association Conference Focuses on Building Sustainable Careers
  • Eichelberger Performing Arts Center Announces Fall 2026 Performance Lineup
  • netElastic Powers LigaT's High-Performance Broadband Expansion and IPv6 Modernization in Portugal
  • IWS Press Expands Best-Selling Classic Wealth Library with Seventh Book
  • Raiku launches rkuSOL with Sanctum, Kamino, Loopscale and Exponent

"COVID-19 was a catalyst that accelerated the clinical trial industry towards embracing technology solutions, such as ClinCard and ConneX," said Jim Murphy, CEO, Greenphire. "Sponsors, CROs and sites quickly appreciated the immense benefits of adding innovative solutions to support their trials, such as higher patient engagement and retention and improved operational efficiencies. We are proud to support this digital movement and enhance the experience for sites in every corner of the globe."

Recognized as leaders in clinical digital innovations in the United Kingdom, having their EU headquarters in Nottingham and more than 1,000 sites supported in the country, Greenphire executives have been asked to host an interactive panel on this growing trend.

Hosted by the Society for Clinical Research Sites (SCRS), the one-hour session titled: Digital Innovation in Clinical Trials: A Conversation with UK Stakeholders, will also feature the unique perspectives of clinical trial site, The University of Aberdeen, and advocate and patient engagement advisor, Trishna Bharadia.

This virtual event is scheduled for May 4, 2021 at 10:00 AM ET and will take a deep dive into current trends and how technology, together with training, is driving the future of clinical trials.

Presenters include:
  • Angela La Ronde, Panel Moderator, Director of Relationship Management, Greenphire UK
  • Trishna Bharadia, Advocate and Patient Engagement Advisor
  • Shaun Treweek, Professor, University of Aberdeen
  • Ben Gordon, Site Trainer, Greenphire UK

For more information or to register for the event visit: https://bit.ly/3tLmfws

More on The PennZone
  • Greenland Mines Ltd (N A S D A Q: GRML) Advances Strategic Growth Initiatives as Critical Minerals Demand Accelerates
  • Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
  • $97.9 Million Q1 Revenue Growth Reinforces Transformation Into a Global AI & Digital Services Powerhouse: IQSTEL, Inc. (N A S D A Q: IQST)
  • Philadelphia Scientist Roohid Parast Applies Evidence-Based Research to Elite Personal Fitness
  • Boston Industrial Solutions Launches Natron® 348 UV Inkjet Ink for Epson S3200 Print Heads

Greenphire is also a co-sponsor of the 11th Annual OCT Europe (Outsourcing in Clinical Trials). The virtual event, hosted from May 5-6, 2021, will center on how to leverage partnerships and expertise to maximize trial success. For more information, visit: https://www.arena-international.com/octeurope/

About Greenphire
Greenphire is the leader in global clinical trial financial process automation. Greenphire's best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire's EnvisiXTM, eClinicalGPS, ClinCard and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.

Media Contact:
Alyson Kuritz
908-892-7149
[email protected]

SOURCE Greenphire

Related Links

http://www.greenphire.com
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Industrial and systems engineers celebrate key leaders in the field at IISE Annual Conference
  • Cosanostra Miami Rises as the Best Latin Nightclub in Miami in Under Two Years From its Opening
  • CCHR Leader's 50-Year Fight for Psychiatric Drug Victims Gains National Momentum
  • Endless Mountain Music Festival Celebrates 21st Season with America250-Inspired Lineup
  • Author Releases 7-Day Screen Time Reset for Families as Teachers Worldwide Report Children "Struggling to Grasp Basic Concepts"
  • Men's Health Month Begins with Record Proclamations, AP News Coverage, & National Momentum for Men's Health
  • Blueshirt Media Launches HIPAA-Compliant AI Call Answering for Addiction Treatment Centers
  • AdvisorVault Adds Social Media Archiving to its Consolidated D3P Service
  • UK Financial Ltd Audits Full Ethereum Architecture Verifies Corporate Wallets and 19-Token Ecosystem Ahead of CoinMarketCap Filing for Global Ranking
  • Creative Investment Research Analysis Finds Slower GDP Growth, Rising Inflation
  • TechHouse Earns Highly Selective Microsoft Support Badge
  • J&J Exterminating Celebrates 65th Anniversary and Unveils Strategic Vision at Annual Team Meeting
  • Tru by Hilton El Paso Airport Opens to Guests
  • Zenylitics Announces Leadership Transition to Continue Accelerated Growth
  • Wellness Technology Distributor Helping People Set Up Wellness Center Businesses
  • Christian Apocalyptic Thriller Explores Biblical Prophecy, Global Technology, & the Rise of the Ant
  • Turnstone Creative Expands Leadership Team with Addition of Marketing Manager
  • The Hidden Price Of Lost Property In UK Schools
  • Milton Collier, CEO & President of Freight Broker 911, Eliminates the #1 Barrier to Entry in Logistics: Announces 100% Free Freight Broker Training
  • FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP

Popular on PennZone

  • People & Stories/Gente y Cuentos Welcomes Two New Trustees as Organization Enters 54th Year and Expands Community Reach
  • Assymetrix Launches the Deepest Independent Prediction Market Data API
  • Resident Inspect Joins Property Meld Nexus Network with API Integration
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan
  • Expert E-Bike Safety Advocate Issues Urgent Warning Following Recent Southern California Fatalities
  • CCHR: 'Plant-Based' Psychedelics Push Masks Synthetic Drugs and Billion-Dollar Profits
  • "I'm Sicka Church Too: Give Me Kingdom!" Ignites a Powerful Call for Healing and Truth
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • Veikkaus Appoints New CFO as Finland's Gambling Monopoly Braces for Breakup

Similar on PennZone

  • AI Is Making It Easier for API-First Platforms to Connect, Partner, Reach Customers, and Grow Revenue Faster
  • 2026 Editorial Freelancers Association Conference Focuses on Building Sustainable Careers
  • Greenland Mines Ltd (N A S D A Q: GRML) Advances Strategic Growth Initiatives as Critical Minerals Demand Accelerates
  • Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
  • $97.9 Million Q1 Revenue Growth Reinforces Transformation Into a Global AI & Digital Services Powerhouse: IQSTEL, Inc. (N A S D A Q: IQST)
  • Boston Industrial Solutions Launches Natron® 348 UV Inkjet Ink for Epson S3200 Print Heads
  • ENTOUCH Recognized on Inc.'s 2026 Best Workplaces List for the Third Year Running
  • Revenue Optics Expands Its Private Equity Practice as Sponsors Move Inside Sales to the Center of Distribution Value Creation
  • Lineus Medical Completes Financial Restructuring with KMF Investments- Launching a New Era for SafeBreak
  • AdvisorVault Adds Social Media Archiving to its Consolidated D3P Service
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us